Orbis Medicines raised DKK 20 million
30 July 2022
30 July 2022
Total investments received (USD): 125.31m
Round value (USD): 2.74m
Round investors:
Novo A/S
Company: Orbis Medicines
Related deals
VenomAid Diagnostics raised $1 million in funding from a Business Angels and the philanthropic venture fund Good Ventures LLC.
Investments
22 January 2023
Breye Therapeutics to raise €4M in a round led by Novo Holdings and Sound Bioventures.
Investments
06 November 2022
Rehaler raised DKK 12 million
Investments
30 October 2022
Stimuliver raised DKK 15 million from Vækstfonden and the life science incubator Bioinnovation Institute.
Investments
01 October 2022
Octarine Bio closes €2M pre-series A fundraising co-led by DSM Venturing and Oskare Capital
Investments
01 September 2022
Belgium
Austria
Germany
Switzerland
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Ireland
Italy
Portugal
Spain
United Kingdom